Intervention Protocol

Perioperative angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers for preventing surgery-related mortality and morbidity

  1. Zui Zou1,
  2. Hong B Yuan1,
  3. Xiao Y Chen2,
  4. Guan J Liu3,
  5. Xue Y Shi1,*

Editorial Group: Cochrane Anaesthesia Group

Published Online: 6 JUL 2011

DOI: 10.1002/14651858.CD009210

How to Cite

Zou Z, Yuan HB, Chen XY, Liu GJ, Shi XY. Perioperative angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers for preventing surgery-related mortality and morbidity (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 7. Art. No.: CD009210. DOI: 10.1002/14651858.CD009210.

Author Information

  1. 1

    Changzheng Hospital, The Second Military Medical University, Department of Anaesthesiology, Shanghai, Shanghai, China

  2. 2

    The General Hospital of the People's Liberation Army (PLAGH) (also Hospital 301), Department of Neurology, Beijing, Beijing, China

  3. 3

    West China Hospital, Sichuan University, Chinese Cochrane Centre, Chinese Evidence-Based Medicine Centre, Chengdu, Sichuan, China

*Xue Y Shi, Department of Anaesthesiology, Changzheng Hospital, The Second Military Medical University, No 415, Feng Yang Road, Shanghai, Shanghai, 200003, China. shixueyin1128@yahoo.com.cn.

Publication History

  1. Publication Status: New
  2. Published Online: 6 JUL 2011

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The objective of this review is to systematically assess the benefits and harms of administration (prophylaxis or treatment or both) of Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II type I receptors blockers (ARBs) in the short-term perioperative period for the prevention of surgery related mortality and morbidity.